34 related articles for article (PubMed ID: 8888974)
1. C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction.
Giannobile WV
Ann N Y Acad Sci; 1999 Jun; 878():404-12. PubMed ID: 10415744
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the clinical performance of the immunoenzymometric assays for N-terminal and C-terminal type I collagen telopeptides and the HPLC assay for pyridinium cross-links.
Bettica P; Masino M; Cucinotta E; Vago T; Norbiato G; Moro L; Suarez KN; Romanello M; Bevilacqua M
Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):63-8. PubMed ID: 9156570
[TBL] [Abstract][Full Text] [Related]
3. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
[TBL] [Abstract][Full Text] [Related]
4. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
[TBL] [Abstract][Full Text] [Related]
5. Comparison of biochemical markers of bone resorption in patients with metabolic and malignant bone diseases.
Withold W; Friedrich W; Reinauer H
Ann Clin Biochem; 1996 Sep; 33 ( Pt 5)():421-7. PubMed ID: 8888974
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers.
Withold W
Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):785-99. PubMed ID: 8933101
[TBL] [Abstract][Full Text] [Related]
7. Biochemical parameters of bone metabolism in bone metastases of solid tumors (review).
Meijer WG; van der Veer E; Willemse PH
Oncol Rep; 1998; 5(1):5-21. PubMed ID: 9458286
[TBL] [Abstract][Full Text] [Related]
8. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
Simsek B; Karacaer O; Karaca I
Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
[TBL] [Abstract][Full Text] [Related]
9. The clinical use of bone resorption markers in patients with malignant bone disease.
Coleman RE
Cancer; 2002 May; 94(10):2521-33. PubMed ID: 12173317
[TBL] [Abstract][Full Text] [Related]
10. [Bone resorption markers].
Takahashi M; Inoue T
Rinsho Byori; 1996 May; 44(5):415-22. PubMed ID: 8676559
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]